| Ronald W Dose, MD | |
|
505 39th Ave, Amana, IA 52203-8229 | |
| (319) 622-3231 | |
| (319) 622-3077 |
| Full Name | Ronald W Dose |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 32 Years |
| Location | 505 39th Ave, Amana, Iowa |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1891763389 | NPI | - | NPPES |
| 56208 | Other | IA | WELLMARK BCBS |
| P00472439 | Other | IA | RAILROAD MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 30764 (Iowa) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Essence Of Life Hospice | Amana, IA | Hospice |
| Mercy Hospital | Iowa city, IA | Hospital |
| Compass Memorial Healthcare | Marengo, IA | Hospital |
| Mercy Medical Center - Cedar Rapids | Cedar rapids, IA | Hospital |
| Colonial Manor Of Amana | Amana, IA | Nursing home |
| Rose Haven Nursing Home | Marengo, IA | Nursing home |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Amana Family Practice Clinic, Pc | 1658363270 | 4 |
News Archive
"Workers who have received their annual enrollment packets for insurance benefits" should expect slight changes to their plans this year due to the health care overhaul. Most employees can expect to pay more next year, due in part to the 1 to 2 percent increase in insurance costs brought about by the law.
eResearchTechnology, Inc. (ERT), a global technology-driven provider of health outcomes research services to biopharmaceutical sponsors and contract research organizations (CROs), today announced that it has entered into a definitive agreement to be acquired by affiliates of Genstar Capital LLC, a leading middle market private equity firm for $8.00 per share in cash in a transaction valued at approximately $400 million.
Cell Therapeutics, Inc. ("CTI") (Nasdaq and MTA: CTIC) announced today that the U.S. Food and Drug Administration (FDA) has notified CTI that a Prescription Drug User Fee Act (PDUFA) action date of April 23, 2010 under standard review has been established regarding CTI's NDA for pixantrone as potential treatment for relapsed or refractory aggressive non-Hodgkin's lymphoma (NHL).
United Food and Commercial Workers (UFCW) members in Ohio today announced their support for the efforts of the Ohio Rights Group and for the Ohio Cannabis Rights Amendment.
Austrian biomarker developer BIOCRATES Life Sciences AG announced today that it entered a co-marketing agreement with Canadian-based CHENOMX Inc. Both enterprises focus on a new and highly promising technology aimed at generating a metabolic profile of the human organism that can be used to monitor the effects of disease, nutrition, toxins, environment, or drugs on an organism.
› Verified 5 days ago
| Entity Name | Amana Family Practice Clinic, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073677019 PECOS PAC ID: 1658363270 Enrollment ID: O20040401001334 |
News Archive
"Workers who have received their annual enrollment packets for insurance benefits" should expect slight changes to their plans this year due to the health care overhaul. Most employees can expect to pay more next year, due in part to the 1 to 2 percent increase in insurance costs brought about by the law.
eResearchTechnology, Inc. (ERT), a global technology-driven provider of health outcomes research services to biopharmaceutical sponsors and contract research organizations (CROs), today announced that it has entered into a definitive agreement to be acquired by affiliates of Genstar Capital LLC, a leading middle market private equity firm for $8.00 per share in cash in a transaction valued at approximately $400 million.
Cell Therapeutics, Inc. ("CTI") (Nasdaq and MTA: CTIC) announced today that the U.S. Food and Drug Administration (FDA) has notified CTI that a Prescription Drug User Fee Act (PDUFA) action date of April 23, 2010 under standard review has been established regarding CTI's NDA for pixantrone as potential treatment for relapsed or refractory aggressive non-Hodgkin's lymphoma (NHL).
United Food and Commercial Workers (UFCW) members in Ohio today announced their support for the efforts of the Ohio Rights Group and for the Ohio Cannabis Rights Amendment.
Austrian biomarker developer BIOCRATES Life Sciences AG announced today that it entered a co-marketing agreement with Canadian-based CHENOMX Inc. Both enterprises focus on a new and highly promising technology aimed at generating a metabolic profile of the human organism that can be used to monitor the effects of disease, nutrition, toxins, environment, or drugs on an organism.
› Verified 5 days ago
| Entity Name | Tiffin Family Care Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588027197 PECOS PAC ID: 6204125115 Enrollment ID: O20160517000681 |
News Archive
"Workers who have received their annual enrollment packets for insurance benefits" should expect slight changes to their plans this year due to the health care overhaul. Most employees can expect to pay more next year, due in part to the 1 to 2 percent increase in insurance costs brought about by the law.
eResearchTechnology, Inc. (ERT), a global technology-driven provider of health outcomes research services to biopharmaceutical sponsors and contract research organizations (CROs), today announced that it has entered into a definitive agreement to be acquired by affiliates of Genstar Capital LLC, a leading middle market private equity firm for $8.00 per share in cash in a transaction valued at approximately $400 million.
Cell Therapeutics, Inc. ("CTI") (Nasdaq and MTA: CTIC) announced today that the U.S. Food and Drug Administration (FDA) has notified CTI that a Prescription Drug User Fee Act (PDUFA) action date of April 23, 2010 under standard review has been established regarding CTI's NDA for pixantrone as potential treatment for relapsed or refractory aggressive non-Hodgkin's lymphoma (NHL).
United Food and Commercial Workers (UFCW) members in Ohio today announced their support for the efforts of the Ohio Rights Group and for the Ohio Cannabis Rights Amendment.
Austrian biomarker developer BIOCRATES Life Sciences AG announced today that it entered a co-marketing agreement with Canadian-based CHENOMX Inc. Both enterprises focus on a new and highly promising technology aimed at generating a metabolic profile of the human organism that can be used to monitor the effects of disease, nutrition, toxins, environment, or drugs on an organism.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ronald W Dose, MD 505 39th Ave, Po Box 207, Amana, IA 52203-8229 Ph: (319) 622-3231 | Ronald W Dose, MD 505 39th Ave, Amana, IA 52203-8229 Ph: (319) 622-3231 |
News Archive
"Workers who have received their annual enrollment packets for insurance benefits" should expect slight changes to their plans this year due to the health care overhaul. Most employees can expect to pay more next year, due in part to the 1 to 2 percent increase in insurance costs brought about by the law.
eResearchTechnology, Inc. (ERT), a global technology-driven provider of health outcomes research services to biopharmaceutical sponsors and contract research organizations (CROs), today announced that it has entered into a definitive agreement to be acquired by affiliates of Genstar Capital LLC, a leading middle market private equity firm for $8.00 per share in cash in a transaction valued at approximately $400 million.
Cell Therapeutics, Inc. ("CTI") (Nasdaq and MTA: CTIC) announced today that the U.S. Food and Drug Administration (FDA) has notified CTI that a Prescription Drug User Fee Act (PDUFA) action date of April 23, 2010 under standard review has been established regarding CTI's NDA for pixantrone as potential treatment for relapsed or refractory aggressive non-Hodgkin's lymphoma (NHL).
United Food and Commercial Workers (UFCW) members in Ohio today announced their support for the efforts of the Ohio Rights Group and for the Ohio Cannabis Rights Amendment.
Austrian biomarker developer BIOCRATES Life Sciences AG announced today that it entered a co-marketing agreement with Canadian-based CHENOMX Inc. Both enterprises focus on a new and highly promising technology aimed at generating a metabolic profile of the human organism that can be used to monitor the effects of disease, nutrition, toxins, environment, or drugs on an organism.
› Verified 5 days ago
Dr. Timothy D Momany, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 505 39th Ave, Pob 207, Amana, IA 52203 Phone: 319-622-3231 Fax: 319-622-3077 |